Biggest News Aggregation in the World
📰 Safety From News

Safety From News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Safety From. Real-time updates on events, politics, business and more.

Ruxolitinib Shows Sustained Efficacy Over Best Available Therapy in Steroid-Refractory/Dependent cGVHD

Treatment with ruxolitinib led to prolonged failure-free survival and improved disease control vs best available treatment in patients with either steroid-refractory or -dependent chronic graft-vs-host disease.
Robert Zeiser Center At University Of Freiburg Medical Center Patients With Chronic Graft Versus Host Disease Year Final Analysis Safety From

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science